SS-31 is a novel mitochondria-targeting peptide designed to protect mitochondrial function and reduce oxidative stress. By stabilizing the mitochondrial inner membrane potential and inhibiting the production of reactive oxygen species (ROS), it helps improve cellular energy metabolism, reduce inflammation, and protect tissues from damage. SS-31 is widely studied for treating diseases related to mitochondrial dysfunction, such as cardiovascular diseases, neurodegenerative disorders, and kidney diseases.
Key Benefits:
-
Protects Mitochondrial Function: Stabilizes the mitochondrial inner membrane potential, improving cellular energy metabolism.
-
Reduces Oxidative Stress: Inhibits ROS production, protecting cells from oxidative damage.
-
Anti-Inflammatory Effects: Reduces inflammatory responses and alleviates tissue damage.
-
Improves Cardiovascular Health: Protects the heart and blood vessels from ischemia-reperfusion injury, enhancing cardiac function.
-
Neuroprotective Effects: Reduces neuronal damage and slows the progression of neurodegenerative diseases.
Target Users:
-
Patients with cardiovascular diseases needing improved heart and vascular health
-
Individuals with neurodegenerative disorders (e.g., Alzheimer's, Parkinson's)
-
Kidney disease patients requiring reduced oxidative stress and inflammation
-
Users seeking to improve mitochondrial function and cellular health
With its unique mitochondria-protecting effects and multiple health benefits, SS-31 is an ideal choice for treating diseases related to mitochondrial dysfunction. Whether for improving cardiovascular health or slowing the progression of neurodegenerative diseases, SS-31 helps you achieve your goals.
